INTERPACE BIOSCIENCES, INC. (IDXG)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 5M 10M 15M Q3 '24: 12.3M Q4 '24: 12.4M Q1 '25: 11.5M Q2 '25: 9.2M Q3 '25: 8.8M Q4 '25: 9.2M Q1 '26: 9M Q2 '26: 9.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 3M 6M 9M Q3 '24: 7.9M Q4 '24: 7.9M Q1 '25: 7.4M Q2 '25: 5.3M Q3 '25: 5.4M Q4 '25: 6M Q1 '26: 5.9M Q2 '26: 5.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income Quarterly

-800K 0 800K 1.6M 2.4M Q3 '24: 2.3M Q4 '24: 2.1M Q1 '25: 1.8M Q2 '25: -468K Q3 '25: 1.1M Q4 '25: 1.6M Q1 '26: 1.1M Q2 '26: 321K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-8M 0 8M 16M 24M Q3 '24: 1.7M Q4 '24: 1.9M Q1 '25: 1.6M Q2 '25: -640K Q3 '25: 911K Q4 '25: 22.7M Q1 '26: 721K Q2 '26: 158K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 2M 4M 6M Q3 '24: 4.4M Q4 '24: 4.5M Q1 '25: 4.1M Q2 '25: 4M Q3 '25: 3.3M Q4 '25: 3.2M Q1 '26: 3.1M Q2 '26: 3.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

0 800K 1.6M 2.4M Q3 '24: 2.1M Q4 '24: 1.2M Q1 '25: 1.2M Q2 '25: 520K Q3 '25: 1.9M Q4 '25: 2.1M Q1 '26: 283K Q2 '26: 98K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-800K 0 800K 1.6M 2.4M Q1 '24: -86K Q2 '24: 1.2M Q3 '24: 1.6M Q4 '24: 1.1M Q3 '25: 1.8M Q4 '25: 2.1M Q1 '26: 142K Q2 '26: 41K Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 10M 20M 30M Q1 '24: 4.4M Q2 '24: 4.4M Q3 '24: 4.4M Q1 '25: 27.7M Q2 '25: 4.4M Q3 '25: 27.7M Q1 '26: 27.7M Q2 '26: 27.7M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.50 1.00 1.50 Q3 '24: 1.34 Q4 '24: 1.41 Q1 '25: 1.31 Q2 '25: 0.62 Q3 '25: 0.27 Q4 '25: 0.77 Q1 '26: 0.74 Q2 '26: 0.89 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.